Cargando…

Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics

BACKGROUND: The model to predict the prognosis of resectable hepatocelluar carcinoma (HCC) has not been determined. METHODS: Predictors were selected using Cox model. Nomograms were generated in the training set and validated in the validation set. The predictive ability of the nomogram was determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Junyi, He, Linye, Li, Chuan, Wen, Tianfu, Chen, Weixia, Lu, Changli, Yan, Lvnan, Li, Bo, Yang, Jiayin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348354/
https://www.ncbi.nlm.nih.gov/pubmed/27811374
http://dx.doi.org/10.18632/oncotarget.13038
_version_ 1782514208797097984
author Shen, Junyi
He, Linye
Li, Chuan
Wen, Tianfu
Chen, Weixia
Lu, Changli
Yan, Lvnan
Li, Bo
Yang, Jiayin
author_facet Shen, Junyi
He, Linye
Li, Chuan
Wen, Tianfu
Chen, Weixia
Lu, Changli
Yan, Lvnan
Li, Bo
Yang, Jiayin
author_sort Shen, Junyi
collection PubMed
description BACKGROUND: The model to predict the prognosis of resectable hepatocelluar carcinoma (HCC) has not been determined. METHODS: Predictors were selected using Cox model. Nomograms were generated in the training set and validated in the validation set. The predictive ability of the nomogram was determined by concordance index and calibration curve. RESULTS: Independent factors for overall survival including alpha-fetoprotein level (hazard ratio (HR):1.292), tumor size (HR:1.092), tumor number (HR:1.472), microvascular invasion (HR:1.660), neutrophil to lymphocyte count ratio (NLR) (HR:1.428), major vascular invasion (HR:2.485) and satellite lesions(HR:1.392) were selected into the nomogram for survival. The c-index in the training set and validation set were 0.767 and 0.719, respectively, which were statistically higher than those of the four conventional staging systems.(Barcelona Clinic Liver Cancer: 0.644 and 0.609; the seventh American Joint Committee on Cancer: 0.678 and 0.674; Cancer of the Liver Italian Program: 0.692 and 0.648; Hong Kong Liver Cancer: 0.689 and 0.639, p < 0.001 for all). A nomogram for predicting 3- and 5-year recurrence free survival was generated with the c-index of 0.746 for the training set and 0.718 for the validation set, respectively. CONCLUSIONS: We have generated nomograms predicting prognosis for HCC treated by hepatectomy with a higher predictive power.
format Online
Article
Text
id pubmed-5348354
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53483542017-03-31 Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics Shen, Junyi He, Linye Li, Chuan Wen, Tianfu Chen, Weixia Lu, Changli Yan, Lvnan Li, Bo Yang, Jiayin Oncotarget Research Paper BACKGROUND: The model to predict the prognosis of resectable hepatocelluar carcinoma (HCC) has not been determined. METHODS: Predictors were selected using Cox model. Nomograms were generated in the training set and validated in the validation set. The predictive ability of the nomogram was determined by concordance index and calibration curve. RESULTS: Independent factors for overall survival including alpha-fetoprotein level (hazard ratio (HR):1.292), tumor size (HR:1.092), tumor number (HR:1.472), microvascular invasion (HR:1.660), neutrophil to lymphocyte count ratio (NLR) (HR:1.428), major vascular invasion (HR:2.485) and satellite lesions(HR:1.392) were selected into the nomogram for survival. The c-index in the training set and validation set were 0.767 and 0.719, respectively, which were statistically higher than those of the four conventional staging systems.(Barcelona Clinic Liver Cancer: 0.644 and 0.609; the seventh American Joint Committee on Cancer: 0.678 and 0.674; Cancer of the Liver Italian Program: 0.692 and 0.648; Hong Kong Liver Cancer: 0.689 and 0.639, p < 0.001 for all). A nomogram for predicting 3- and 5-year recurrence free survival was generated with the c-index of 0.746 for the training set and 0.718 for the validation set, respectively. CONCLUSIONS: We have generated nomograms predicting prognosis for HCC treated by hepatectomy with a higher predictive power. Impact Journals LLC 2016-11-03 /pmc/articles/PMC5348354/ /pubmed/27811374 http://dx.doi.org/10.18632/oncotarget.13038 Text en Copyright: © 2016 Shen et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Shen, Junyi
He, Linye
Li, Chuan
Wen, Tianfu
Chen, Weixia
Lu, Changli
Yan, Lvnan
Li, Bo
Yang, Jiayin
Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
title Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
title_full Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
title_fullStr Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
title_full_unstemmed Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
title_short Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
title_sort prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348354/
https://www.ncbi.nlm.nih.gov/pubmed/27811374
http://dx.doi.org/10.18632/oncotarget.13038
work_keys_str_mv AT shenjunyi prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT helinye prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT lichuan prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT wentianfu prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT chenweixia prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT luchangli prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT yanlvnan prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT libo prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics
AT yangjiayin prognosticnomogramsforpatientswithresectablehepatocelluarcarcinomaincorporatingsystemicinflammationandtumorcharacteristics